Gastrointestinal adverse events after dual Antiplatelet therapy: Clopidogrel is safer than Ticagrelor, but Prasugrel data are lacking or inconclusive

Victor L. Serebruany, James J. Dinicolantonio, Mehmet Mustafa Can, Igor V. Pershukov, Wiktor Kuliczkowski

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Gastrointestinal adverse events after dual Antiplatelet therapy: Clopidogrel is safer than Ticagrelor, but Prasugrel data are lacking or inconclusive'. Together they form a unique fingerprint.

Medicine & Life Sciences